Anti-GD2 CAR T cells could prove transformative for H3-K27M+ diffuse midline gliomas

被引：2
|
作者：
Furukawa, Koichi [1 ]
Ohmi, Yuhsuke [2 ]
Furukawa, Keiko [1 ]
机构：
[1] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Mtaumoto 1200, Kasugai, Aichi 4878501, Japan
[2] Chubu Univ, Coll Life & Hlth Sci, Dept Clin Engn, Kasugai, Aichi, Japan
来源：
TRANSLATIONAL CANCER RESEARCH | 2019年 / 8卷
基金：
日本学术振兴会;
关键词：
ENZYME-MEDIATED ACTIVATION; G(D3) SYNTHASE GENE; LUNG-CANCER; MONOCLONAL-ANTIBODIES; EXPRESSION CLONING; GD2; GANGLIOSIDE; RADICAL SOURCES; STEM-CELLS; GROWTH; PROLIFERATION;
D O I：
10.21037/tcr.2018.08.21
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：S87 / S93
页数：7
相关论文
共 50 条
  • [31] USE OF MRNA FOR SAFE AND EFFECTIVE GD2-DIRECTED CAR T CELLS TO TREAT DIFFUSE MIDLINE GLIOMAS
    Foster, Jessica
    Griffin, Crystal
    Stern, Allison
    Brimley, Cameron
    Storm, Phillip
    Barrett, David
    Resnick, Adam
    NEURO-ONCOLOGY, 2021, 23 : 30 - 31
  • [32] Imaging Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3 K27M Mutation
    Aboian, M. S.
    Solomon, D. A.
    Felton, E.
    Mabray, M. C.
    Villanueva-Meyer, J. E.
    Mueller, S.
    Cha, S.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2017, 38 (04) : 795 - 800
  • [33] Prediction of H3K27M mutation status of diffuse midline gliomas using MRI features
    Chauhan, Richa Singh
    Kulanthaivelu, Karthik
    Kathrani, Nihar
    Kotwal, Abhishek
    Bhat, Maya Dattatraya
    Saini, Jitender
    Prasad, Chandrajit
    Chakrabarti, Dhritiman
    Santosh, Vani
    Uppar, Alok Mohan
    Srinivas, Dwarakanath
    JOURNAL OF NEUROIMAGING, 2021, 31 (06) : 1201 - 1210
  • [34] MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas
    Abe, Hideaki
    Natsumeda, Manabu
    Okada, Masayasu
    Watanabe, Jun
    Tsukamoto, Yoshihiro
    Kanemaru, Yu
    Yoshimura, Junichi
    Oishi, Makoto
    Hashizume, Rintaro
    Kakita, Akiyoshi
    Fujii, Yukihiko
    FRONTIERS IN ONCOLOGY, 2020, 9
  • [35] THE ONCOGENIC ROLE OF THE SUPER ELONGATION COMPLEX IN H3K27M-MUTANT DIFFUSE MIDLINE GLIOMAS
    Dahl, Nathan A.
    Venkataraman, Sujatha
    Balakrishnan, Ilango
    Madhavan, Krishna
    Fosmire, Susan
    Vibhakar, Rajeev
    NEURO-ONCOLOGY, 2018, 20 : 50 - 50
  • [36] DISSECTING THE EFFECT OF ATM DELETION ON RADIOSENSITIVITY IN DIFFUSE MIDLINE GLIOMAS WITH H3K27M MUTATION
    Garcia, Maria Guerra
    Deland, Katherine
    Luo, Lixia
    Ma, Yan
    Williams, Nerissa
    Stewart, Connor
    Kirsch, David
    Reitman, Zachary
    NEURO-ONCOLOGY, 2021, 23 : 20 - 20
  • [37] CLINICAL AND MOLECULAR CHARACTERIZATION OF ADULT DIFFUSE MIDLINE GLIOMAS, H3 K27M-MUTANT
    Grassl, N.
    Suwala, A.
    Kessler, T.
    Etminan, N.
    Unterberg, A.
    Breckwoldt, M.
    Bendszus, M.
    Groden, C.
    Debus, J.
    Ehmann, M.
    Wick, W.
    Sahm, F.
    Platten, M.
    Sahm, K.
    NEURO-ONCOLOGY, 2024, 26
  • [38] HISTONE H3 PHOSPHORYLATION IN H3K27M MIDLINE GLIOMAS
    Zhang, Liang
    Day, Charles
    Hinchcliffe, Edward
    Daniels, David
    NEURO-ONCOLOGY, 2020, 22 : 302 - 302
  • [39] Major tumor regressions in H3K27M-mutated diffuse midline glioma (DMG) following sequential intravenous (IV) and intracerebroventricular (ICV) delivery of GD2-CAR T cells
    Majzner, Robbie G.
    Mahdi, Jasia
    Ramakrishna, Sneha
    Patel, Shabnum
    Chinnasamy, Harshini
    Yeom, Kristen
    Schultz, Liora
    Barsan, Valentin
    Richards, Rebecca
    Campen, Cynthia
    Reschke, Agnes
    Toland, Angus Martin Shaw
    Baggott, Christina
    Mavroukakis, Sharon
    Egeler, Emily
    Moon, Jennifer
    Jacobs, Ashley
    Yamabe-Kwong, Karen
    Rasmussen, Lindsey
    Nie, Esther
    Green, Sean
    Kunicki, Michael
    Fujimoto, Michelle
    Ehlinger, Zach
    Reynolds, Warren
    Prabhu, Snehit
    Warren, Katherine E.
    Cornell, Tim
    Partap, Sonia
    Fisher, Paul
    Grant, Gerald
    Vogel, Hannes
    Sahaf, Bita
    Davis, Kara
    Feldman, Steven
    Monje, Michelle
    Mackall, Crystal L.
    CANCER RESEARCH, 2022, 82 (12)
  • [40] ANTI-GD2 CAR T CELLS AGAINST SMALL CELL LUNG CANCER
    Neri, G.
    Chiavelli, C.
    Trudu, L.
    Prapa, M.
    Golinelli, G.
    Pugliese, G.
    Silingardi, M.
    Rovesti, G.
    Grisendi, G.
    Bestagno, M.
    Spano, C.
    Benati, D.
    Recchia, A.
    Masciale, V.
    Bertolini, F.
    Dominici, M.
    CYTOTHERAPY, 2023, 25 (06) : S243 - S244
12345